Showing results (61-70 of 632) with videos related to
Sort By:
Pageof 64
Pharmacoepidemiology and Drug Safety|October 16, 2003
Risk factors for adverse events in analgesic drug users: results from the PAIN studyNicholas Moore, Andrew Charlesworth, Eric Van Ganse, et al.International Journal of Chronic Obstructive Pulmonary Disease|November 7, 2019
Dual versus triple therapy in patients hospitalized for COPD in France: a claims data studyFaustine Dalon, Nicolas Roche, Manon Belhassen, et al.BMC Public Health|September 17, 2009
Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional surveyLaurent Laforest, Eric Van Ganse, Cécile Ritleng, et al.BMC Pulmonary Medicine|April 4, 2014
Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational studyNicolas Roche, Céline Pribil, Eric Van Ganse, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 23, 2008
Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based surveyLaurent Laforest, Eric Van Ganse, Gilles Devouassoux, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 5, 2006
Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugsLaurent Laforest, Philippe Moulin, Marie-Sophie Schwalm, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2013
Evidence on the global measurement model of the Minnesota Living with Heart Failure QuestionnaireOlatz Garin, Montse Ferrer, Àngels Pont, et al.BMC Health Services Research|January 28, 2025
Distinct phenotypes of patients and healthcare resource utilization after hospitalization for COVID-19: an observational studyClaire Marant Micallef, Manon Belhassen, Florence Ader, et al.Vaccine|December 28, 2020
Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World DataClarisse Marchal, Manon Belhassen, Nicole Guiso, et al.Archives of Cardiovascular Diseases|November 12, 2019
Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in FrancePaul Guedeney, Victor Aboyans, Faustine Dalon, et al.Pageof 64